A Win For Sienna Biopharmaceuticals, Inc.
Wed, Dec 18, 2019 at 05:30 PM
Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ) soared at $0.14, representing a gain of 30.7%. The stock got featured on our News Catalysts scanner on Fri 13 Dec 19 at 12:16 PM in the 'RECOMMENDATION' category. From Tue 26 Nov 19, the stock recorded 35.71% Up Days and 46.67% Green Days
About Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ)
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.
Top 10 Gainers:
- Mirum Pharmaceuticals, Inc. (MIRM:NASDAQ), 44.09%
- McDermott International, Inc. (MDR:NYSE), 37.67%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Reed's, Inc. (REED:NASDAQ), 30.35%
- Reed's, Inc. (REED:NYSEMKT), 30.35%
- YayYo, Inc. (YAYO:NASDAQ), 30.16%
- Inpixon (INPX:NASDAQ), 29.91%
- PhaseBio Pharmaceuticals, Inc. (PHAS:NASDAQ), 27.57%
- LAIX Inc. (LAIX:NYSE), 25.3%
- TSR, Inc. (TSRI:NASDAQ), 24.83%